Redmile Group, Llc's Net Worth

Redmile Group, Llc's net worth is estimated to be at least $244,386,134.92 as of 05/21/2024. CoreStreet's estimation of Redmile Group, Llc's net worth is based on their sale of stock and current holding of stock.

Redmile Group, Llc is Director at Absci Corp. They have executed at least 24 trades of stock as per SEC Form 4 filings. Their most recent trade was for 222,222 units of ABSI stock on 03/01/2024. Their biggest sale was on 09/28/2016 when they sold 2,492,578 units of Array Technologies Inc stock for $15,852,796.08. They typically trade 3 times per year.

Total value of insider buys:
  • $228,533,338.84
Total value of insider sells:
  • $15,852,796.08
Most recent insider trade:
  • March 1, 2024

Redmile Group, Llc's Insider Trading History

Absci CorpTitleAmountPriceTypeTotal Value
March 1, 2024
Director222,222$4.50Buy$999,999.00
Fate Therapeutics IncTitleAmountPriceTypeTotal Value
Dec. 26, 2023
Director44,630$3.72Buy$166,023.60
April 20, 2023
Director20,000$5.99Buy$119,800.00
April 14, 2023
Director25,700$6.00Buy$154,200.00
Jan. 8, 2021
Director327,485$85.50Buy$27,999,967.50
June 11, 2020
Director1,412,928$28.31Buy$39,999,991.68
Sept. 16, 2019
Director857,143$17.50Buy$15,000,002.50
Sept. 25, 2018
Director3,703,704$13.50Buy$50,000,004.00
Shattuck LabsĀ IncTitleAmountPriceTypeTotal Value
Oct. 14, 2020
Director3,441,176$17.34Buy$59,669,991.84
IGM Biosciences IncTitleAmountPriceTypeTotal Value
Sept. 8, 2020
Director47,113$49.91Buy$2,351,409.83
Sept. 3, 2020
Director74,253$48.69Buy$3,615,378.57
Sept. 1, 2020
Director41,759$44.84Buy$1,872,473.56
Neoleukin TherapeuticsTitleAmountPriceTypeTotal Value
April 2, 2020
Major Shareholder39,300$11.37Buy$446,841.00
March 30, 2020
Major Shareholder32,500$9.94Buy$323,050.00
March 27, 2020
Major Shareholder50,000$9.21Buy$460,500.00
Array Technologies IncTitleAmountPriceTypeTotal Value
Sept. 28, 2016
Major Shareholder2,492,578$6.36Sell$15,852,796.08
Sept. 15, 2016
Major Shareholder400,000$3.51Buy$1,404,000.00
Jan. 20, 2016
Major Shareholder300,000$3.19Buy$957,000.00
Jan. 12, 2016
Major Shareholder75,000$3.60Buy$270,000.00
Jan. 11, 2016
Major Shareholder925,000$3.67Buy$3,394,750.00
Oct. 1, 2015
Major Shareholder782,592$4.58Buy$3,584,271.36
Aug. 25, 2015
Major Shareholder790,000$5.38Buy$4,250,200.00
Aug. 10, 2015
Major Shareholder1,048,993$5.80Buy$6,084,159.40
Syros Pharmaceuticals IncTitleAmountPriceTypeTotal Value
July 6, 2016
Major Shareholder432,746$12.50Buy$5,409,325.00